Medstar Health Research Institute
OrganisationROR
People
Scientific director, biomarker core, reporter.nih.gov
Scientific director, 14 Sept 2026, reporter.nih.gov
Scientific director, implementation sci, 24 Jul 2024, reporter.nih.gov
Trials
Collaborator, Phase 2, Recruiting, 2026, 30 people, 18 May 2026, clinicaltrials.gov
The INTERvening for LUNG Health Trial
Collaborator, Phase 4, Not yet recruiting, 2026, 800 people, 20 Apr 2026, clinicaltrials.gov
Phase 4, Completed, 2017, 130 people, 17 Aug 2018, clinicaltrials.gov
Spironolactone for Pulmonary Arterial Hypertension
Collaborator, Phase 2, Recruiting, 2014, 70 people, 23 Oct 2012, clinicaltrials.gov
Collaborator, Phase 2, Completed, 2005, 126 people, 1 Nov 2011, clinicaltrials.gov
Phase 2, Terminated, 2009, 2 people, 17 Dec 2008, clinicaltrials.gov
Phase 1, Completed, 2008, 19 people, 17 Jul 2008, clinicaltrials.gov
Collaborator, Phase 4, Withdrawn, 2013, 0 people, 13 Dec 2007, clinicaltrials.gov
Phase 4, Withdrawn, 2006, 0 people, 7 Mar 2007, clinicaltrials.gov
Phase 2, Withdrawn, 1999, 0 people, 4 May 2004, clinicaltrials.gov
Phase 2, Terminated, 2000, 4 people, 26 Feb 2004, clinicaltrials.gov
Phase 2, Completed, 1999, 30 people, 27 Jan 2003, clinicaltrials.gov
Grants and prizes
National Heart, Lung, and Blood Institute
N01, STRONG HEART STUDY (SHS) - MEDSTAR HEALTH RESEARCH INSTITUTE, INC., FIELD CENTER (FC), TASK AREA C: DATA BOOK, 75N92019D00, US$129k, 2026–2027, reporter.nih.gov
R01, Glucose homeostasis and the risk of Alzheimer's disease and Alzheimer's disease related dementias in the Multi-Ethnic Study of Atherosclerosis, R01AG070881, US$856.7k, 2021–2031, 14 Sept 2026, reporter.nih.gov
Agency for Healthcare Research and Quality
R18, Bridging the gap: Delivering Equitable Colorectal Cancer Screening, R18HS029807, US$493.9k, 2023–2028, 24 Jul 2024, reporter.nih.gov